期刊文献+

人乳头瘤病毒16型野毒株L1-E7融合基因重组腺病毒载体构建及在293细胞中表达嵌合病毒样颗粒的研究 被引量:4

Construction of an attenuated recombinant adenoviral vaccine of human papillomavirus type 16 L1-E7 and expression of the chimeric virus like particles in 293 cells
原文传递
导出
摘要 目的 制备人乳头瘤病毒HPV16L1 E7重组腺病毒 ,以期获得防治宫颈癌的重组腺病毒减毒活疫苗。方法 以HPV16型的野毒株HPV16 114/K为模板 ,利用PCR克隆技术制备HPV16L1 E7融合基因pUC19L1 E7,含L1的 1~ 30 1氨基酸 (AA)和E7的 1~ 6 0AA的编码DNA序列 ;并转入腺病毒穿梭质粒pCA14L1 E7,与腺病毒质粒pBHG10共转染 2 93细胞 ,筛选重组腺病毒rAd5HPV16L1 E7。以PCR、ELISA和Westernblot方法鉴定重组病毒及其表达的L1 E7蛋白 ,密度梯度超速离心纯化HPV16嵌合L1 E7VLP ,电镜观察VLP的形态结构。结果 PCR DNA序列分析表明成功构建了HPV16L1 E7重组质粒pUC19L1 E7;并获得HPV16重组腺病毒rAd5HPV16L1 E7,在 2 93细胞中可高效表达L1 E7蛋白 ,并形成嵌合病毒样颗粒 (cVLP)。结论 构建的重组腺病毒rAd5HPV16L1 E7可有效表达HPV16L1 E7cVLP ,可进一步用于动物实验 。 Objective Human papillomaviruses can not be cultured in vitro now, and have tumorgenicity. These properties of HPV severely hampered the vaccine development of human papillomavirus. In order to develop an attenuated recombinant adenovirus vaccine against HPV infection and human cervical cancer, the recombinant adenoviral of HPV16 was constructed. Methods The plasmid pUC19L1 E7 contained L1 ORF and E7 ORF was constructed using polymerase chain reaction. The L1 E7 DNA fragment was digested with HindⅢand SmaⅠ and inserted into pBluescript, to prepare pBSL1 E7. The L1 E7 DNA fragment was cut with HindⅢ and XbaⅠ and inserted into adenoviral shuttle plasmid pCA14, and then cotransfected 293 cells with the adenovirus pBHG10 plasmid, harvested the recombinant adenovirus of HPV16. The expression of the chimeric virus like particle was detected using ELISA, immunoblot assay and the electron microscopy. Results The fusion L1 E7 protein was expressed at high level and able to self assemble into chimeric virus like particle (cVLP), which is morphologically indistinguishable from the native virions and display the conformational epitopes. Conclusion We constructed the recombinant adenovirus of human papillomavirus type 16L1 E7, the L1 E7 fusion protein can be expressed in high level, and can self assemble into the chimeric virus like particles in human cells. The recombinant pUC19L1 plasmid was an potential vector for constructing other chimeric vaccines with the epitopes derived from virus and tumor antigen.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2001年第4期368-372,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金 (396 70 0 38) 山东省自然科学基金(Y96C10 0 42 )资助项目
关键词 乳头状瘤病毒 病毒样颗粒 腺病毒载体 疫苗 宫颈肿瘤 宫颈癌 Papillomavirus Virus like particle Adenovirus vector Vaccine Cervical neoplasms
  • 相关文献

参考文献4

共引文献2

同被引文献13

  • 1施桥发,魏晓丽,李虹,王保宁,张卫东,蒋忠华,曹康,李明远.HPV16 E5蛋白原核表达、鉴定及真核表达稳定株的筛选[J].南方医科大学学报,2006,26(1):31-35. 被引量:2
  • 2Frankfurt QS, Seckinget D, Sugarbaker EV. Pleiortopic drug resistance and survival advantage in leukemia cells with diminished apoptosis response. Int J Cancer, 1994,59: 217-223.
  • 3Herman JR, Adler HL, Aguilar Cordova E, et al. In situ gene therapy for adenocarcinoma of the prostate:a phase I clinical tria.Hum Gene Ther, 1999,10.1239-1244.
  • 4Gurunathan S, Klinman DM, Seder RA. DNA vaccines:immunology, application and optimization [R]. Annu Rev Immunol, 2000, 18:927~974.
  • 5Steinwaerder DS, Carlson CA, Lieber A. Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes [J].Molecular Therapy, 2001, 4(3):211~216.
  • 6Rebuffat A, Bernasconi A, Ceppi M, et al. Selective enhancement of gene transfer by steroid-mediated gene delivery[J]. Nature Biotechnol, 2001, 19(12):1 155~1 169.
  • 7Sato Y, Roman M, Tighe J, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization[J]. Science, 1996, 273, 352~354.
  • 8左凤琼,赵素兰,李婉宜,李晓红,吕梅励,蒋中华,李明远,欧阳运薇.人乳头瘤病毒16L1原核表达质粒的构建[J].四川生理科学杂志,2008,30(4):152-153. 被引量:1
  • 9叶传忠,陈仕平,裴雪涛,冯凯,李梁,杨光.脂质体介导的HSV-TK基因治疗人膀胱癌[J].中华实验外科杂志,1999,16(1):24-25. 被引量:9
  • 10栾怡,于修平,宋长芹,卞继峰,阎世坤,赵蔚明,贾继辉,周亚滨,齐眉.HPV16L1-E7蛋白疫苗诱导小鼠产生抗体及细胞免疫应答的研究[J].山东大学学报(医学版),2002,40(4):302-304. 被引量:2

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部